Annual Cash & Cash Equivalents
$6.81 M
+$5.63 M+478.17%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual cash & cash equivalents is currently $6.81 million, with the most recent change of +$5.63 million (+478.17%) on 31 December 2023. During the last 3 years, it has risen by +$6.14 million (+917.83%). GDTC annual cash & cash equivalents is now at all-time high.GDTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.77 M
-$2.04 M-29.97%
30 June 2024
Summary:
CytoMed Therapeutics Limited quarterly cash and cash equivalents is currently $4.77 million, with the most recent change of -$2.04 million (-29.97%) on 30 June 2024. Over the past year, it has dropped by -$2.93 million (-38.03%). GDTC quarterly cash and cash equivalents is now -38.03% below its all-time high of $7.70 million, reached on 30 June 2023.GDTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +478.2% | -38.0% |
| 3 y3 years | +917.8% | - |
| 5 y5 years | - | - |
GDTC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +917.8% | -38.0% | +346.7% |
| 5 y | 5 years | at high | +917.8% | -38.0% | +346.7% |
| alltime | all time | at high | +917.8% | -38.0% | +346.7% |
CytoMed Therapeutics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $4.77 M(-30.0%) |
| Dec 2023 | $6.81 M(+478.2%) | $6.81 M(-11.5%) |
| June 2023 | - | $7.70 M(+553.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.18 M(-36.6%) | $1.18 M(+10.3%) |
| June 2022 | - | $1.07 M(-42.5%) |
| Dec 2021 | $1.86 M(+177.7%) | $1.86 M |
| Dec 2020 | $669.10 K | - |
FAQ
- What is CytoMed Therapeutics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual cash & cash equivalents year-on-year change?
- What is CytoMed Therapeutics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
What is CytoMed Therapeutics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of GDTC is $6.81 M
What is the all time high annual cash & cash equivalents for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual cash & cash equivalents is $6.81 M
What is CytoMed Therapeutics Limited annual cash & cash equivalents year-on-year change?
Over the past year, GDTC annual cash & cash equivalents has changed by +$5.63 M (+478.17%)
What is CytoMed Therapeutics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GDTC is $4.77 M
What is the all time high quarterly cash and cash equivalents for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly cash and cash equivalents is $7.70 M
What is CytoMed Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, GDTC quarterly cash and cash equivalents has changed by -$2.93 M (-38.03%)